IINX yields 200000000.00% · JNJ yields 2.14%● Live data
📍 IINX pulled ahead of the other in Year 1
Combined, IINX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IINX + JNJ for your $10,000?
Ionix Technology, Inc., together with its subsidiaries, engages in the research and development, manufacture, and marketing of liquid crystal materials, displays, and modules in the United States, Hong Kong, and the People's Republic of China. It operates through three segments: Smart Energy, Photoelectric Display, and Service Contracts. The company provides electronic equipment, such as power banks for iphone, ipad, mp3/mp4 players, PSP gaming systems, and cameras; and liquid crystal module and liquid crystal display screens for video capable baby monitors, tablets and cell phones, and televisions or computer monitors. It distributes its products to distributors and retailers. The company was formerly known as Cambridge Projects Inc. and changed its name to Ionix Technology, Inc. in February 2016. Ionix Technology, Inc. was incorporated in 2011 and is based in Dalian, China. Ionix Technology, Inc. is a subsidiary of Shining Glory Investments Limited.
Full IINX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.